Lyonbiopôle | Newsletter

Décember 2016

2016 ends in beauty and we wish you a year full of projects for 2017.

>> Discover our animated greeting card <<

MORE proximity,

MORE exchanges,

MORE projects,

MORE reactivity

The beginning of the year 2017 will be more connected at Lyonbiopole...

We will meet you in early January for more information!

			8th edition of the Nosocomial Infections DayThis edition of the Nosocomial Infections Day was organized by Lyonbiopole and Finovi. 75 participants representing academic, clinic and industrial communities were gathered and were able to connect with perspectives of potential future collaborations in mind. 3 topics have been tackled: bacterial genomics, innovative therapeutic approaches and new vaccine approaches. [...]
			Lyonbiopole members rewarded at the 2016 Innovation TrophiesDuring the 11th edition of the Innovation Trophies of Bref Eco, two Lyonbiopole member companies were rewarded: Noveal e-santé and Theranexus. [...]

			New memberMdp designs micro-electric motor solutions for the medical market and develops, thanks to its integrated mechatronics engineering department, undeniable know-how in the development of medical devices incorporating electric micro-motors. [...]
			New memberMessenger Biopharma is a French biotech company dedicated to research on messenger RNA. This latter is taken up by cells, in vivo as well as ex vivo, in human or animals, in order to immunize them or to treat numerous diseases. [...]

Décember 2^nd, 2016Imaxio sells Trolovol®	Décember 2^nd, 2016ERYTECH presents new data	Décember 7^th, 2016PDC*line Pharma raises €4 million
Décember 9^th, 2016EDAP Receives the Prestigious Prix Galien	Décember 14^th, 2016Valneva starts clinical testing of Lyme disease vaccine	Décember 16^th, 2016ElsaLys Biotech acquires rights of Transgene's anti-CD115 antibody
Décember 19^th, 2016Adocia and Lilly announce completion of an insulin pump study	Décember 19^th, 2016ENYO Pharma SA announces initiation of the Phase 1 clinical programme with EYP001	Décember 19^th, 2016EDAP Reports Superior Outcomes of Focal Ablatherm-HIFU Compared to Robotic Radical Prostatectomy
Décember 20^th, 2016Three Novasep custom manufacturing sites renew FDA approval in 2016	Décember 21^th, 2016Enyo Pharma receives a €2.5 million grant